• Home
  • Stocks
  • Sun Pharma Advanced Research Company Ltd.

Sun Pharma Advanced Research Company Ltd.

View in App
222.65 +0.05 ▲0.0%

26 September 2023, 04:01:00 PM
Volume: 67,469

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sparc.life
Market Cap 7,259.55 Cr.
Enterprise Value(EV) 7,148.02 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) -7.26 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-06
Industry PE 37.33 Trailing Twelve Months Ending 2023-06
Book Value / Share 12.86 Trailing Twelve Months Ending 2023-06
Price to Book Value 17.39 Calculated using Price: 223.70
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 32.45 Cr. 324,521,588 Shares
FaceValue 1
About Sun Pharma Advanced Research Company Ltd.
The company is engaged in the pharmaceutical research and development. The company's core focus is innovation and new product development for global markets. SPARC undertakes projects in research and technology for new chemical entities (NCE's) or new molecules, and novel drug delivery systems (NDDS).

Sun Pharma Advanced Research Company Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Sun Pharma Advanced Research Company Ltd. Performance

View details >>
1 Day
+0.02%
1 Week
-5.11%
1 Month
+1.44%
3 Month
+15.27%
6 Month
+28.85%
1 Year
+2.58%
2 Year
-23.34%
5 Year
-38.73%
10 Year
+69.95%

Sun Pharma Advanced Research Company Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -33.17 -109.16 -127.40 -156.84 -74.72 -225.08 -143.72
Return on Capital Employed (%) -31.74 -71.37 -94.66 -113.05 -59.95 -178.95 -254.10 -225.57 -69.44
Return on Assets (%) -23.65 -44.68 -53.72 -66.85 -40.89 -93.11 -60.18 -79.80 -40.10

Sun Pharma Advanced Research Company Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 139 100 32 158 185 296 -19 -168 31 513
Non Curr. Liab. 9 10 10 10 12 7 56 165 77 138
Curr. Liab. 39 37 125 108 116 95 235 233 171 179
Minority Int.
Equity & Liab. 188 147 167 277 313 398 273 230 280 830
Non Curr. Assets 77 83 99 118 138 141 205 167 209 375
Curr. Assets 110 63 67 158 175 257 67 60 71 455
Misc. Exp. not W/O 1 0 1
Total Assets 188 147 167 277 313 398 273 230 280 830

Sun Pharma Advanced Research Company Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 156 161 181 78 183 77 253 137 239 234
Other Income 3 3 14 5 14 10 5 7 11 21
Total Income 159 164 195 83 196 87 258 144 250 255
Total Expenditure -191 -224 -304 -321 -334 -387 -388 -324 -453 -472
PBIDT -32 -60 -109 -238 -138 -300 -130 -180 -203 -217
Interest 0 -2 -2 0 0 -3 -11 -13 -8 -6
Depreciation -7 -8 -8 -8 -8 -9 -11 -10 -12 -12
Taxation
Exceptional Items 49
PAT -40 -70 -119 -197 -145 -312 -151 -203 -223 -236
Adjusted EPS -2 -3 -5 -8 -6 -12 -6 -7 -7 -8

Sun Pharma Advanced Research Company Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 37 -41 -44 -128 -183 -172 -211 -152 -208 -69
Cash Fr. Inv. 44 53 -13 -7 -105 -102 155 2 -29 -548
Cash Fr. Finan. -81 -1 51 194 224 274 55 159 229 617
Net Change 0 11 -7 60 -63 0 9 -8 -1
Cash & Cash Eqvt 0 11 4 64 0 0 0 9 1 1

Sun Pharma Advanced Research Company Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 68.46 68.10 68.10 69.09 69.09 69.09 68.22 65.67 65.67
Public 31.54 31.90 31.90 30.91 30.91 30.91 31.78 34.33 34.33
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 2.29 2.29 2.29 2.18 2.18 1.65 1.02 2.78 2.78

Sun Pharma Advanced Research Company Ltd. Announcements

View details >>
Tue, 26 Sep 2023
Intimation Of Incorporation Of Wholly Owned Subsidiary Company
Intimation of Incorporation of Wholly Owned Subsidiary
Fri, 22 Sep 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
As attached
Fri, 22 Sep 2023
Appointment of Company Secretary and Compliance Officer
Intimation for Appointment of Company Secretary & Compliance Officer and Key Managerial Personnel of the Company.

Sun Pharma Advanced Research Company Ltd. Technical Scans

View details >>
Tue, 26 Sep 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Opening at Low Opening at Low
Making Lower Lows for 3 days Making Lower Lows for 3 days

Sun Pharma Advanced Research Company Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 269,865.20 1,124.75 +0.1%
Divi's Laboratories Ltd. 99,629.03 3,752.95 +0.6%
Cipla Ltd. 93,955.61 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. 91,199.58 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. 72,659.42 5,051.00 -0.9%
Mankind Pharma Ltd. 70,114.99 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. 61,876.29 1,831.00 -0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 31.99 1,124.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-06 67.44 3,752.95 +0.6%
Cipla Ltd. Consolidated 2023-06 30.20 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.31 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 108.63 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 54.64 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 49.18 1,831.00 -0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.65 1,124.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-06 7.59 3,752.95 +0.6%
Cipla Ltd. Consolidated 2023-06 3.86 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.72 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.58 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 5.72 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.42 1,831.00 -0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,124.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,752.95 +0.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,831.00 -0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,124.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,752.95 +0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,831.00 -0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,124.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,752.95 +0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,831.00 -0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,124.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,752.95 +0.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,831.00 -0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,124.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,752.95 +0.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,163.80 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,468.10 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,051.00 -0.9%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,748.55 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,831.00 -0.9%

Sun Pharma Advanced Research Company Ltd. FAQ's

What is Sun Pharma Adv. Res share price?
Can I buy Sun Pharma Adv. Res shares now?
What is the Market Cap of Sun Pharma Adv. Res?
What are the key metrics to analyse Sun Pharma Adv. Res?
What is the 52 Week High and Low of Sun Pharma Adv. Res?
What is the trend of Sun Pharma Adv. Res share price?